Allison Heddon

Allison is a nationally recognized virtual health leader with expertise in the telemedicine landscape including legislation, reimbursement trends and technology vendor platforms, as well significant experience in virtual health strategic planning, financial analysis and implementation.

Allison is currently the Global Market Strategy Lead of the Digital Transformation Healthcare & Life Sciences Practice for Cisco. She is responsible for global market sizing, the identification of global market trends and demands for solutions and services, and strategic plan development. Allison focuses on driving growth, competitive edge and innovation within DTG.

Prior to joining Cisco, Allison founded and led the virtual health division at Sg2, a leading market intelligence and thought leadership firm in the US healthcare industry. Within this role, she shaped corporate messaging and guided enterprise-wide technology acquisition strategies and virtual health implementation for US and international organizations. She was also responsible for leading large-scale virtual health projects within Sg2 Consulting. During her tenure at the firm, Allison led the development of Sg2’s proprietary STEP (Sg2 Technology Evaluation and Prioritization) tool, designed a multiyear series on disruptive health care technology, facilitated numerous health system technology strategic planning retreats, and managed global technology assessments for large international technology vendors and pharmaceutical companies.

Allison is the co-founder and telemedicine advisor for Resonance Medical, LLC, a software company that develops embedded software solutions that help medical device company partners reduce power consumption and increase information transfer between the device and the brain. These devices include cochlear implants, retinal implants, deep brain stimulators, and spinal cord stimulators. Because these devices communicate directly with the brain, increasing information transfer and reducing power consumption improves patient outcomes, increases devices performance, and opens up new possibilities for smaller, more integrated, brain-machine interfaces.

Allison was named a 2014 “20 In Their 20s” by Crain’s Chicago Business, and her work has been published in the Journal of Medical Ethics. She is a frequent speaker at technology conferences and events across the country, is a manuscript reviewer for the Telemedicine and e-Health journal and has led innovation workshops at Singularity University’s Exponential Medicine Conference.

Allison earned her master’s degree in bioethics and health policy from Loyola University Chicago and her bachelor’s degree in biology from Illinois Wesleyan University.